Case series: anesthetic management of patients with spinal and bulbar muscular atrophy (Kennedy's disease)

被引:0
作者
Niesen, Adam D. [1 ]
Sprung, Juraj [1 ]
Prakash, Y. S. [1 ,2 ]
Watson, James C. [3 ]
Weingarten, Toby N. [1 ]
机构
[1] Mayo Clin, Coll Med, Dept Anesthesiol, Rochester, MN 55905 USA
[2] Mayo Clin, Coll Med, Dept Physiol & Biomed Engn, Rochester, MN 55905 USA
[3] Mayo Clin, Coll Med, Dept Neurol, Rochester, MN 55905 USA
来源
CANADIAN JOURNAL OF ANAESTHESIA-JOURNAL CANADIEN D ANESTHESIE | 2009年 / 56卷 / 02期
关键词
BULBOSPINAL NEURONOPATHY; SKELETAL-MUSCLE;
D O I
10.1007/s12630-008-9018-1
中图分类号
R614 [麻醉学];
学科分类号
100217 ;
摘要
Kennedy's disease (KD) is a rare, X-linked recessive, neurodegenerative disorder of lower motor neurons characterized by progressive proximal limb and bulbar muscular atrophy with spontaneous laryngospasm, which may present an anesthetic risk. We undertook a computerized search of the Mayo Clinic medical records database between January 1996 and May 2008 for patients with KD undergoing general anesthesia. Medical records were reviewed for anesthetic techniques and perioperative complications. We identified six patients with KD, confirmed by DNA testing, who underwent 13 general anesthetics. Succinylcholine was used in two patients, and non-depolarizing neuromuscular blockers in seven cases, all without adverse effects. Although laryngospasm was not identified in any patient, one patient with advanced disease experienced postoperative glottic edema, worsening respiratory distress, bulbar dysfunction, requiring tracheostomy and prolonged ventilatory support. One patient experienced a pneumothorax. The potential for bulbar dysfunction and muscle weakness in patients with KD places them at risk for perioperative complications from anesthesia. Anesthesia providers should be cognizant of the different potential anesthetic risk factors in these patients.
引用
收藏
页码:136 / 141
页数:6
相关论文
共 50 条
[41]   Overturning the Paradigm of Spinal Muscular Atrophy as Just a Motor Neuron Disease [J].
Yeo, Crystal Jing Jing ;
Darras, Basil T. .
PEDIATRIC NEUROLOGY, 2020, 109 :12-19
[42]   Label-free morphology-based phenotypic analysis of spinal and bulbar muscular atrophy muscle cell models [J].
Sakakibara, Kenji ;
Tanaka, Kenjiro ;
Iida, Madoka ;
Imai, Yuta ;
Okada, Mai ;
Sahashi, Kentaro ;
Hirunagi, Tomoki ;
Maeda, Kentaro ;
Kato, Ryuji ;
Katsuno, Masahisa .
DISEASE MODELS & MECHANISMS, 2025, 18 (06)
[43]   Gene therapy with AR isoform 2 rescues spinal and bulbar muscular atrophy phenotype by modulating AR transcriptional activity [J].
Lim, Wooi F. ;
Forouhan, Mitra ;
Roberts, Thomas C. ;
Dabney, Jesse ;
Ellerington, Ruth ;
Speciale, Alfina A. ;
Manzano, Raquel ;
Lieto, Maria ;
Sangha, Gavinda ;
Banerjee, Subhashis ;
Conceicao, Mariana ;
Cravo, Lara ;
Biscans, Annabelle ;
Roux, Loic ;
Pourshafie, Naemeh ;
Grunseich, Christopher ;
Duguez, Stephanie ;
Khvorova, Anastasia ;
Pennuto, Maria ;
Cortes, Constanza J. ;
La Spada, Albert R. ;
Fischbeck, Kenneth H. ;
Wood, Matthew J. A. ;
Rinaldi, Carlo .
SCIENCE ADVANCES, 2021, 7 (34)
[44]   Beta-agonist stimulation ameliorates the phenotype of spinal and bulbar muscular atrophy mice and patient-derived myotubes [J].
Milioto, Carmelo ;
Malena, Adriana ;
Maino, Eleonora ;
Polanco, Maria J. ;
Marchioretti, Caterina ;
Borgia, Doriana ;
Pereira, Marcelo Gomes ;
Blaauw, Bert ;
Lieberman, Andrew P. ;
Venturini, Roberta ;
Plebani, Mario ;
Sambataro, Fabio ;
Vergani, Lodovica ;
Pegoraro, Elena ;
Soraru, Gianni ;
Pennuto, Maria .
SCIENTIFIC REPORTS, 2017, 7
[45]   Spinal muscular atrophy: a motor neuron disorder or a multi-organ disease? [J].
Shababi, Monir ;
Lorson, Christian L. ;
Rudnik-Schoeneborn, Sabine S. .
JOURNAL OF ANATOMY, 2014, 224 (01) :15-28
[46]   Spinal muscular atrophy: Broad disease spectrum and sex-specific phenotypes [J].
Singh, Natalia N. ;
Hoffman, Shaine ;
Reddi, Prabhakara P. ;
Singh, Ravindra N. .
BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE, 2021, 1867 (04)
[47]   Efficacy and safety of leuprorelin acetate for subjects with spinal and bulbar muscular atrophy: pooled analyses of two randomized-controlled trials [J].
Hashizume, Atsushi ;
Katsuno, Masahisa ;
Suzuki, Keisuke ;
Banno, Haruhiko ;
Takeuchi, Yu ;
Kawashima, Motoshi ;
Suga, Noriaki ;
Mano, Tomoo ;
Araki, Amane ;
Hijikata, Yasuhiro ;
Hirakawa, Akihiro ;
Sobue, Gen ;
Sasaki, H. ;
Aoki, M. ;
Nakano, I ;
Ito, S. ;
Mizusawa, H. ;
Yamamoto, To ;
Hasegawa, K. ;
Miyajima, H. ;
Kanda, N. ;
Nakajima, K. ;
Tsujino, A. ;
Uchino, M. ;
Morita, M. ;
Kanai, K. .
JOURNAL OF NEUROLOGY, 2019, 266 (05) :1211-1221
[48]   SMN protein is required throughout life to prevent spinal muscular atrophy disease progression [J].
Zhao, Xin ;
Feng, Zhihua ;
Risher, Nicole ;
Mollin, Anna ;
Sheedy, Josephine ;
Ling, Karen K. Y. ;
Narasimhan, Jana ;
Dakka, Amal ;
Baird, John D. ;
Ratni, Hasane ;
Lutz, Catherine ;
Chen, Karen S. ;
Naryshkin, Nikolai A. ;
Ko, Chien-Ping ;
Welch, Ellen ;
Metzger, Friedrich ;
Weetall, Marla .
HUMAN MOLECULAR GENETICS, 2022, 31 (01) :82-96
[49]   Quantification of disease progression in spinal muscular atrophy with muscle MRI-a pilot study [J].
Otto, Louise A. M. ;
Froeling, Martijn ;
van Eijk, Ruben P. A. ;
Asselman, Fay-Lynn ;
Wadman, Renske ;
Cuppen, Inge ;
Hendrikse, Jeroen ;
van der Pol, W-Ludo .
NMR IN BIOMEDICINE, 2021, 34 (04)
[50]   Adiponectin and Leptin-Considerations in Adult Patients with Spinal Muscular Atrophy Type 3 [J].
Miletic, Marija ;
Stevic, Zorica ;
Peric, Stojan ;
Gajic, Milina Tancic ;
Rakocevic, Jelena ;
Stojanovic, Milos ;
Markovic, Bojan ;
Zarkovic, Milos .
DIAGNOSTICS, 2025, 15 (05)